Nivagen Pharmaceuticals Closes $16 Million Growth Equity Financing from Telegraph Hill Partners
Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities SACRAMENTO, Calif.--(BUSINESS WIRE)--Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals...